This content is only available in German.
Dieser Inhalt ist nur auf Deutsch verfügbar.

0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
0900 712 713

(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. in the waiting loop by network operator)

Notfallnummern

Anmeldung

Sie haben bereits ein Konto?

 

Sie sind noch nicht registriert?

Hotline for child and youth emergencies

The Medgate Kids Line provides fast and simple medical advice when your child is unwell. The medical team from our partner Medgate is available by phone around the clock.

 
 

0900 712 712

(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. by network operator)

 
 

0900 712 713

(3.13 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)

Please note: the Medgate Kids Line is currently offered in German.

 
 

Important Numbers

  • 144   Ambulance
  • 145   Tox Center (Poisoning)
  • 117   Police
  • 118   Fire Department

Kontakt Box

Pediatric Endocrinology and Diabetology

Over the last two years projects have been realized with local, national and international collaborators in Endocrinology and Diabetology. Further, as a result of strong partnership with Pediatric Pharmacology UKBB (Prof Pfister) the digital health project OptiThyDose was granted by BRCCH in 2022 (https://brc.ch/research/optithydose/).

Diabetology

First, the DiaHEART study, in teamwork with Prof Donner, Pediatric Cardiology UKBB, is described in detail in Autonomic cardiac regulation during nocturnal hypoglycemia in diabetic children (Pediatr Diabetes 2021). Second, a comprehensive quality of life study describes the psychosocial burden and fear of hypoglycemia in parents and their children with type 1 diabetes (Front Endocrinol 2022). Finally, the DiaCAMP and DiaMONITOR studies combining continuous parallel measurement of physical activity and heart rate with routine glucose sensor data over 7 days have been realized. The aim of these studies is to develop personalized recommendations to predict and avoid hypoglycemia in children with type 1 diabetes. These data are currently being analyzed in collaboration with Pediatric Pharmacology UKBB (Prof Pfister), Computer Science and Machine Learning ETH Zürich (Prof Vogt), and Computational Systems Biology ETH Zürich (Dr Kaltenbach).

Endocrinology

Based on retrospective longitudinal clinical data from four pediatric centers (Basel, Zürich, St.Gallen, Bern) we developed with the teams of Pediatric Pharmacology UKBB (Prof Pfister) and Department of Mathematics, University of Konstanz (Prof Schropp), algorithms for optimal personalized dosing for neonates with congenital hypothyroidism and children with hyperthyroidism (JPKPD 2021, J Optim Theory Appl 2021). As a next step, clinical validation of these algorithms is planned in the context of the BRCCH-granted OptiThyDose study together with Prof Pfister’s and Prof Schroppp’s teams. The OptiThyDose study is designed as a large multicenter prospective randomized controlled trial. Participating clinical partners are Hôpital Necker, Paris (Prof Polak), Ospedale Bambino Gesù, Rome (Prof Cappa) and Arabkir Medical Center in Yerewan, Armenia (Prof Navasardyan). The ultimate aim is to provide simple personalized dosing to children with thyroid diseases.

Only available in German

 

Research group leader

 
Print
You can also find us here
UKBB FacebookUKBB YoutubeUKBB LinkedInUKBB Instagram

Emergencies

0900 712 712

(3.23 CHF/min. CH-landline, possibly additionally 8 Rp. / min. by network operator)

0900 712 713

(3.12 CHF/min. prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)

Site Map

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
Contact

 

Emergency

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
Contact

© UKBB, 2024

Datenschutzhinweis

Diese Website verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Website stimmen Sie der Verwendung von Cookies und ähnlichen Technologien zu. Weitere Informationen finden Sie in unserer Datenschutzerklärung.

[x]

ErlaubenAblehnen